Advertisement
Screener

FURIEX PHARMACEUTICALS, INC. Operating Cash Flow

FURIEX PHARMACEUTICALS, INC. Operating Cash Flow

FURIEX PHARMACEUTICALS, INC. reported Operating Cash Flow of -$9.17 million for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-09.

Discontinued › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2014-05-09

  • FURIEX PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2014-03-31 was -$9.17M, a 196.06% decline year-over-year.
  • FURIEX PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2013-12-31 was -$6.55M.
  • FURIEX PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2013-09-30 was -$17.07M.
  • FURIEX PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2013-06-30 was -$9.06M.
  • FURIEX PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2013 was -$23.14M.
  • FURIEX PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2012 was -$40.63M.
  • FURIEX PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2011 was -$49.00M.
  • FURIEX PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2010 was -$43.32M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 12 month
2014-03-31-$9.17M
10-Q · filed 2014-05-09
-$15.72M
derived: sum of 2 quarters · filed 2014-05-09
-$32.78M
derived: sum of 3 quarters · filed 2014-05-09
-$41.85M
derived: sum of 4 quarters · filed 2014-05-09
2013-12-31-$6.55M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17
-$23.62M
derived: sum of 2 quarters · filed 2014-03-17
-$32.68M
derived: sum of 3 quarters · filed 2014-03-17
-$23.14M
10-K · filed 2014-03-17
2013-09-30-$17.07M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12
-$26.13M
derived: sum of 2 quarters · filed 2013-11-12
-$16.59M
10-Q · filed 2013-11-12
-$30.91M
derived: sum of 4 quarters · filed 2014-05-09
2013-06-30-$9.06M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08
$480.00K
10-Q · filed 2013-08-08
-$13.85M
derived: sum of 3 quarters · filed 2014-05-09
-$22.51M
derived: sum of 4 quarters · filed 2014-05-09
2013-03-31$9.54M
10-Q · filed 2014-05-09
-$4.78M
derived: sum of 2 quarters · filed 2014-05-09
-$13.45M
derived: sum of 3 quarters · filed 2014-05-09
-$19.09M
derived: sum of 4 quarters · filed 2014-05-09
2012-12-31-$14.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17
-$22.99M
derived: sum of 2 quarters · filed 2014-03-17
-$28.63M
derived: sum of 3 quarters · filed 2014-03-17
-$40.63M
10-K · filed 2014-03-17
2012-09-30-$8.66M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12
-$14.31M
derived: sum of 2 quarters · filed 2013-11-12
-$26.31M
10-Q · filed 2013-11-12
-$38.09M
derived: sum of 4 quarters · filed 2014-03-17
2012-06-30-$5.64M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08
-$17.64M
10-Q · filed 2013-08-08
-$29.43M
derived: sum of 3 quarters · filed 2014-03-17
-$40.31M
derived: sum of 4 quarters · filed 2014-03-17
2012-03-31-$12.00M
10-Q · filed 2013-05-09
-$23.79M
derived: sum of 2 quarters · filed 2014-03-17
-$34.66M
derived: sum of 3 quarters · filed 2014-03-17
-$46.94M
derived: sum of 4 quarters · filed 2014-03-17
2011-12-31-$11.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17
-$22.66M
derived: sum of 2 quarters · filed 2014-03-17
-$34.94M
derived: sum of 3 quarters · filed 2014-03-17
-$49.00M
10-K · filed 2014-03-17
2011-09-30-$10.88M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06
-$23.15M
derived: sum of 2 quarters · filed 2012-11-06
-$37.22M
10-Q · filed 2012-11-06
-$47.21M
derived: sum of 4 quarters · filed 2013-03-18
2011-06-30-$12.28M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07
-$26.34M
10-Q · filed 2012-08-07
-$36.33M
derived: sum of 3 quarters · filed 2013-03-18
-$43.11M
derived: sum of 4 quarters · filed 2013-03-18
2011-03-31-$14.06M
10-Q · filed 2012-05-07
-$24.05M
derived: sum of 2 quarters · filed 2013-03-18
-$30.84M
derived: sum of 3 quarters · filed 2013-03-18
2010-12-31-$9.99M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18
-$16.77M
derived: sum of 2 quarters · filed 2013-03-18
-$43.32M
10-K · filed 2013-03-18
2010-09-30-$6.78M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10
-$33.33M
10-Q · filed 2011-11-10
2010-06-30-$26.55M
10-Q · filed 2011-08-10
2009-12-31-$24.15M
10-K · filed 2012-03-07